The PreTRM® Test provides you with your patient’s risk for spontaneous premature birth in asymptomatic singleton pregnancies. This pivotal information provided in the form of an individual risk percentage gives you sufficient time and vital insights to make informed treatment decisions with your patients.
With an incidence of one in ten pregnancies, preterm birth is considered by many medical experts to be a public health crisis. The emotional, financial, and long-term health implications for preterm babies and their families can be overwhelming. Up until this point, ways to accurately predict the risk of a preterm delivery have been limited, with only a small percentage of high risk patients identified through clinical or demographic risk factors.
Until recently, clinicians have had limited resources for predicting the risk of spontaneous preterm birth. Traditional indicators of increased risk such as short cervical length and a positive history for previous spontaneous preterm birth fail to detect 80% of spontaneous preterm births.
Given the limitations of current risk factors to predict the risk of premature birth, scientists at Sera Prognostics set out to discover a biomarker prediction that would provide an early individual risk of assessment for spontaneous preterm birth. Researchers discovered that two proteins combined with biometric variables provides highly accurate prediction of spontaneous preterm birth in asymptomatic singleton pregnancies.